TRUE™ Tissue Technology

Our proprietary TRUE™ Tissue technology platform is currently available for investigational use only.

TRUE™ Tissue developed from cells isolated from donor tissue and is 100% biological. There are no synthetic materials or chemical fixation used, and implanted tissues are completely cell-derived and acellular.

That’s how we make tissues that are TRUE to Nature™.

Preclinical in vivo and in vitro testing has demonstrated that TRUE™ Tissue is:

  • Non-calcific
  • Non-immunogenic
  • Regenerative
  • Mechanically comparable to native tissue
  • Ready to use, off-the-shelf allograft
Discover the difference TRUE™ Tissue makes as an implantable biomaterial platform. TRUE™ Tissue can be readily manufactured for a range of medical devices, implantation sites and geometries. It’s time to replace synthetic biomaterials with TRUE™ Tissue technology and enjoy the benefits of staying TRUE to Nature™.

Contact us to discuss how you can implement TRUE™ Tissue technology in the development of your medical device.

TRUE™ Vascular Graft
TRUE™ Heart Valve
TRUE™ Patch

TRUE™ Tissue Technology Pipeline


Autm better world project image

Vascudyne’s TRUE Tissue Technology is a Top 3 2022 Better World Project Award Finalist

Regenerative Medicine Vascular Graft for Hemodialysis Access

Regenerative Medicine Company Vascudyne Closes $10 Million Series A Financing

Vascudyne announces successful First Human Use of TRUE™ Vascular Graft for hemodialysis access

Vascudyne’s CSO presents at the Heart Valve Society Meeting on tissue remodeling of engineered valved conduit evaluated at 52 weeks in the growing lamb

Lab-created heart valves can grow with the recipient article published in Science Translational Medicine

Proud Member of:

5 + 2 =

Copyright 2021 | Vascudyne, Inc.